Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Spectral AI, Inc. - Warrants (NQ: MDAIW )

0.1600 +0.0100 (+6.67%)
Streaming Delayed Price Updated: 11:24 AM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,740
Open 0.1465
Bid (Size) 0.1380 (10)
Ask (Size) 0.1500 (1)
Prev. Close 0.1500
Today's Range 0.1424 - 0.1600
52wk Range 0.1003 - 0.3895
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Spectral AI Schedules 2024 First Quarter Financial Results and Conference Call
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary
Spangenberg brings significant IP monetization experience and the potential to unlock additional value for Spectral AI shareholders 
From Spectral AI, Inc.
Via GlobeNewswire

Performance

YTD
-32.91%
-32.91%
1 Month
-23.81%
-23.81%
3 Month
-25.62%
-25.62%
6 Month
+14.29%
+14.29%
1 Year
+33.33%
+33.33%

More News

Read More
Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Announces 2023 Fourth Quarter and Full Year Financial Results
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Secures Access to $12.5 Million of New Equity Capital
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Announces Receipt of $1 Million of Financing for Spectral IP, Inc., its Intellectual Property Subsidiary Focused on the Broader Artificial Intelligence Ecosystem
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference Call
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Announces New US Government Contract to Further Accelerate the Development of the Handheld Version of DeepView™ Wound Imaging System
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Announces Intellectual Property Subsidiary to Focus on the Broader AI Healthcare Ecosystem
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Appoints Peter M. Carlson as CEO
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI to Participate in Upcoming Investor Conferences
From Spectral AI, Inc.
Via GlobeNewswire
Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Appoints Dr. J. Michael DiMaio to Board of Directors
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Announces Publication of Letter to Shareholders
From Spectral AI, Inc.
Via GlobeNewswire
Spectral Submits Application for UKCA Mark Classification
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI® for Burn Injuries
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Names Industry Veteran and Former Top MiMedx Financial Executive Peter M. Carlson as CFO
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI to Participate in Benchmark’s 12th Annual Discovery One-on-One Conference
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Appoints Erich Spangenberg as Chairman of the Executive Committee of the Board of Directors
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Announces 2023 Third Quarter Financial Results
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Schedules 2023 Third Quarter Financial Results and Conference Call
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI names Prof. Paul Chadwick, Former CEO of the Royal College of Podiatry UK, as Senior Executive for UK and EMEA
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI Provides 2023-2024 Annual Revenue Guidance
From Spectral AI, Inc.
Via GlobeNewswire
Spectral AI’s DeepView SnapShot® Wound Imaging System, Achieves UKCA Mark and FDA Class 1 Medical Device Classification
From Spectral AI, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.